MetLife Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,971
| Closed | -$69.6K | – | 2828 |
|
|
2024
Q4 | $69.6K | Sell |
22,971
-11,119
| -33% | -$33.7K | ﹤0.01% | 2710 |
|
|
2024
Q3 | $125K | Hold |
34,090
| – | – | ﹤0.01% | 2533 |
|
|
2024
Q2 | $139K | Buy |
34,090
+3,388
| +11% | +$13.9K | ﹤0.01% | 2447 |
|
|
2024
Q1 | $484K | Hold |
30,702
| – | – | ﹤0.01% | 1693 |
|
|
2023
Q4 | $465K | Hold |
30,702
| – | – | ﹤0.01% | 1734 |
|
|
2023
Q3 | $616K | Buy |
30,702
+5,158
| +20% | +$103K | ﹤0.01% | 1501 |
|
|
2023
Q2 | $721K | Buy |
25,544
+608
| +2% | +$17.2K | 0.01% | 1455 |
|
|
2023
Q1 | $429K | Hold |
24,936
| – | – | ﹤0.01% | 1736 |
|
|
2022
Q4 | $502K | Hold |
24,936
| – | – | ﹤0.01% | 1643 |
|
|
2022
Q3 | $540K | Buy |
24,936
+5,271
| +27% | +$114K | ﹤0.01% | 1584 |
|
|
2022
Q2 | $553K | Hold |
19,665
| – | – | ﹤0.01% | 1583 |
|
|
2022
Q1 | $907K | Buy |
19,665
+7,139
| +57% | +$329K | 0.01% | 1395 |
|
|
2021
Q4 | $1.05M | Hold |
12,526
| – | – | 0.01% | 1107 |
|
|
2021
Q3 | $835K | Buy |
12,526
+678
| +6% | +$45.2K | 0.01% | 1219 |
|
|
2021
Q2 | $630K | Hold |
11,848
| – | – | 0.01% | 1435 |
|
|
2021
Q1 | $514K | Hold |
11,848
| – | – | ﹤0.01% | 1506 |
|
|
2020
Q4 | $615K | Buy |
11,848
+6,771
| +133% | +$352K | 0.01% | 1373 |
|
|
2020
Q3 | $166K | Sell |
5,077
-5,077
| -50% | -$166K | ﹤0.01% | 1974 |
|
|
2020
Q2 | $488K | Buy |
+10,154
| New | +$488K | 0.01% | 1395 |
|